Immediate Impact

2 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
2024 Standout
1 intermediate paper

Works of Ayako Mitsuma being referenced

A phase I study of LCL161, a novel oral pan‐inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors
2022
A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors
2013

Author Peers

Author Last Decade Papers Cites
Ayako Mitsuma 288 187 118 43 521
Saradhi Mallampati 151 267 91 33 572
Hele Everaus 177 172 98 36 575
Florence Namour 186 180 55 29 617
Phb Willemse 298 100 60 33 510
Nathan D. Seligson 202 181 156 38 502
Antonin Schmitt 263 201 114 48 533
Antonella Ingrosso 241 190 161 25 619
Meral Günaldı 271 168 107 54 617
Masako Uno 147 181 87 37 521
María Apellániz-Ruiz 266 176 212 35 645

All Works

Loading papers...

Rankless by CCL
2026